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Résumé en
anglais
Extracellular vesicles (EVs), including microvesicles (MVs) and exosomes, are small
vesicles secreted from a wide variety of cells. Whereas MVs are particles released
by the outward budding of the plasma membrane, exosomes are derived from
endocytic compartments. Secretion of EVs can be enhanced by specific stimuli, and
increased plasma circulating levels of EVs have been correlated with
pathophysiological situations. MVs, already present in the blood of healthy
individuals, are considerably elevated in several cardiovascular diseases associated
with inflammation, suggesting that they can mediate deleterious effects such as
endothelial dysfunction or thrombosis. Nonetheless, very recent studies also
demonstrate that MVs may act as biological information vectors transferring
proteins or genetic material to maintain cell homeostasis, favor cell repair, or even
promote angiogenesis. Additionally, exosomes have also been shown to have pro-
angiogenic and cardio-protective properties. These beneficial effects, therefore,
reveal the potential therapeutical use of EVs in the field of cardiovascular medicine
and regenerative therapy. In this review, we will provide an update of cellular
processes modulated by EVs of specific interest in the treatment of cardiovascular
pathologies. A special focus will be made on the morphogen sonic hedgehog (Shh)
associated with EVs (EVsShh+), which have been shown to mediate many pro-
angiogenic effects. In addition to offer a potential source of cardiovascular markers,
therapeutical potential of EVs reveal exciting opportunities to deliver specific
agents by non-immunogenic means to cardiovascular system.
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